This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Technology Companies: CS Disco (LAW) and Infineon Technologies AG (OtherIFNNF)

Tipranks - Fri May 8, 10:04AM CDT

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on CS Disco (LAW) and Infineon Technologies AG (IFNNF) with bullish sentiments.

Claim 55% Off TipRanks

CS Disco (LAW)

Needham analyst Scott Berg maintained a Buy rating on CS Disco today and set a price target of $10.00. The company’s shares closed last Thursday at $4.04.

According to TipRanks.com, Berg is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -7.4% and a 37.9% success rate. Berg covers the Technology sector, focusing on stocks such as Via Transportation, Inc. Class A, ServiceTitan, Inc. Class A, and Zeta Global Holdings Corp. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for CS Disco with a $8.00 average price target, representing a 109.4% upside. In a report released today, Canaccord Genuity also maintained a Buy rating on the stock with a $6.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Infineon Technologies AG (IFNNF)

In a report released today, Dirk Schlamp from DZ BANK AG maintained a Buy rating on Infineon Technologies AG. The company’s shares closed last Thursday at $72.60.

Schlamp has an average return of 2.9% when recommending Infineon Technologies AG. ;'>

According to TipRanks.com, Schlamp is ranked #3352 out of 12228 analysts.

Currently, the analyst consensus on Infineon Technologies AG is a Strong Buy with an average price target of $71.76, implying a -0.7% downside from current levels. In a report issued on April 24, TipRanks – xAI also upgraded the stock to Buy with a EUR60.00 price target.

Read More on LAW:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.